4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-21-042986
Chief Executive Officer bought 3,000 shares at $5.11 ($15,330)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schambye Hans T. Chief Executive Officer | 2021-06-24 | Purchase | +3,000 | $5.11 | $15,330 | 42,928 | D |
| Open-market purchases · 3,000 sh · avg $5.11 · $15,330 | |||||||
Loading xslF345X03/doc4.xml…